These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3837514)

  • 1. Heparin-free hemodialysis with Cuprophan hollow fiber dialyzers by a frequent saline flush, high blood flow technique.
    Agresti J; Conroy JD; Olshan A; Conroy JF; Schwartz A; Brodsky I; Krevolin L; Chinitz J
    Trans Am Soc Artif Intern Organs; 1985; 31():590-4. PubMed ID: 3837514
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical usefulness of Nephral ST dialyzers in hemodialyzed patients with increased risk of bleeding].
    Kopeć J; Sułowicz W
    Przegl Lek; 2010; 67(2):91-4. PubMed ID: 20557006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical aspects of high-flux hemodiafiltration for adequate short (under 2 hours) treatment.
    Miller JH; von Albertini B; Gardner PW; Shinaberger JH
    Trans Am Soc Artif Intern Organs; 1984; 30():377-81. PubMed ID: 6533911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin is unable to prevent contact activation by three different membranes.
    Stratta P; Canavese C; Mangiarotti G; Pacitti A; Tetta C; Coppo R; Ragni R; Vercellone A
    Proc Eur Dial Transplant Assoc; 1981; 18():269-74. PubMed ID: 6460241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialyzer fiber bundle volume during hemodialysis using large-surface dialyzers.
    Leblanc M; Lafrance JP; Renald A
    ASAIO J; 2006; 52(6):646-51. PubMed ID: 17117054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dialysis treatment using a low dialysis flow].
    Mann H; Stiller S; Plache H; Walther OE; Schwartz R
    Verh Dtsch Ges Inn Med; 1974; 80():692-5. PubMed ID: 4454638
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary technical and clinical evaluation of a new hollow fiber dialyzer with a 5 microns thick cuprophan membrane.
    Ronco C; Brendolan A; Bragantini L; Chiaramonte S; Fabris A; Feriani M; Dell'Aquila R; Milan M; La Greca G
    Clin Nephrol; 1986; 26 Suppl 1():S17-21. PubMed ID: 3829463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous hemodialysis with cuprophan membranes in critical patients].
    Cotera A; Lorca E; Saffie A; Sepulveda M
    Rev Med Chil; 1994 Apr; 122(4):394-400. PubMed ID: 7809533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large surface area dialysis; innovations and patient management.
    Smith LJ
    Nurs Clin North Am; 1975 Sep; 10(3):481-90. PubMed ID: 1041630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced treatment time: hemodialysis (HD) versus hemofiltration (HF).
    Keshaviah P; Berkseth R; Ilstrup K; McMichael C; Collins A
    Trans Am Soc Artif Intern Organs; 1985; 31():176-82. PubMed ID: 3837440
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study of the behavior of peripheral blood leukocytes in patients under hemodialysis].
    Massola VC; Ianhez LE; Silveira N; Sabbaga E
    AMB Rev Assoc Med Bras; 1972 Jul; 18(7):271-4. PubMed ID: 4538789
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sequential ultrafiltration with hemodialysis in treating chronic kidney failure].
    Kulakov GP; Konovalov GA; Melikian AM; Makarova KM
    Urol Nefrol (Mosk); 1983; (1):34-9. PubMed ID: 6829090
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin free hemodialysis does not cause fibrin consumptive coagulopathy and maintains alternate pathway complement activation.
    Liboro R; Schwartz AB; Conroy J; Conroy J; Brezin J; Vanderlinde RE; Krevolin L; Brodsky I
    ASAIO Trans; 1990; 36(2):86-9. PubMed ID: 2340212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal replacement therapy utilizing hemodialysis and peritoneal dialysis.
    Paganini EP; Vidt DG
    Urol Clin North Am; 1983 May; 10(2):347-67. PubMed ID: 6344391
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of severe fluid overload by ultrafiltration.
    Silverstein ME; Ford CA; Lysaght MJ; Henderson LW
    N Engl J Med; 1974 Oct; 291(15):747-51. PubMed ID: 4416729
    [No Abstract]   [Full Text] [Related]  

  • 19. [12 or 16 hours of hemodialysis weekly? A Czechoslovak coil dialyzer, 2 x 6 or 2 x 8 hours weekly].
    Lisý Z; Tomásek R
    Cas Lek Cesk; 1985 Sep; 124(37):1170-4. PubMed ID: 4042131
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodialysis without anticoagulants: efficiency and hemostatic aspects.
    Casati S; Moia M; Graziani G; Cantaluppi A; Citterio A; Mannucci PM; Ponticelli C
    Clin Nephrol; 1984 Feb; 21(2):102-5. PubMed ID: 6723110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.